Motivate, Vaccinate, Activate: Increasing RSV vaccination among Latino older adults
Motivate, Vaccinate, Activate’: An effectiveness-implementation trial to assess the impact of a multi-component community-based intervention to increase RSV vaccine uptake among Latino older adults
A community program using community health worker counseling and text-message nudges to help Latino older adults get the new RSV vaccine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11375021 on NIH RePORTER |
What this research studies
You would be offered a community-led program that uses trusted community health workers and tailored text-message reminders to encourage RSV vaccination. The team will adapt methods that worked during the COVID-19 response with Unidos en Salud and then randomly compare the intervention to usual outreach to see which gets more people vaccinated. They will also gather information on who is reached, whether people liked the approach, and how much it costs so other communities can use the same tactics.
Who could benefit from this research
Good fit: Latino older adults who are eligible for RSV vaccination and live in the study area, especially those connected to local community organizations.
Not a fit: People who are not Latino, who live outside the study area, or who are already vaccinated would likely not receive direct benefit from joining this trial.
Why it matters
Potential benefit: If successful, this could raise RSV vaccination rates and help lower RSV-related hospitalizations and deaths among Latino older adults.
How similar studies have performed: Related community health worker and text-message strategies helped boost COVID-19 vaccination in Latino communities, but applying them specifically to RSV uptake is a new effort.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Marquez, Carina — University of California, San Francisco
- Study coordinator: Marquez, Carina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.